Race Oncology Ltd has initiated its first Australian clinical site for a Phase 1 trial testing a reformulated version of its lead cancer drug, RC220, in patients with advanced solid tumours.
The site, Southside Cancer Care Centre in Miranda, New South Wales, is the first to be set up for the trial, which will eventually run across locations in Australia, Hong Kong and South Korea. Governance approval is still pending before patient recruitment can begin.
Abacus Global Management (NASDAQ:ABL) reported a 40% increase in fourth-quarter revenue, reaching $33.2 million, as the alternative asset manager expanded its operations through strategic acquisitions and capital deployment.
For the full year 2024, revenue surged 69% to $111.9 million, while adjusted net income climbed 58% to $46.5 million.
Falcon Gold Corp (TSX-V:FG, OTC:FGLDF) announced that it has completed its third drill hole at the Great Burnt copper-gold project in Newfoundland and is finalizing the fourth hole, with preparations underway for drilling at Pad #5.
Recent drilling has revealed encouraging mineralization, including blebby to stringer sulphides, transitioning to semi-massive and massive sulphide bands, the company said in a statement on Thursday.
T Stamp Inc (NASDAQ:IDAI, EURONEXT:AIID) (dba Trust Stamp) said Thursday it expects revenue from existing customers to exceed $5 million in 2025.
The company announced the revenue figures alongside strong fourth-quarter results for 2024.
GameStop Corp (NYSE:GME) shares have pulled back after the video game retailer announced a planned $1.3 million debt issue of convertible notes due in 2030 to purchase Bitcoin in addition to funding general corporate activities.
Shares of GameStop fell 12% to about $25, erasing gains from Wednesday’s session.
EnWave Corp (TSX-V:ENW, OTC:NWVCF) has signed a master service agreement with US-based pharmaceutical contract manufacturer BioTechnique to evaluate the use of its Radiant Energy Vacuum (REV) dehydration technology as a potential alternative to lyophilization in the biopharmaceutical sector, the company said on Thursday.
As part of the initial collaboration, BioTechnique will conduct paid testing of several liquid products using pilot-scale REV machinery at EnWave’s Innovation Center in British Columbia.
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) shares rose 5% on Thursday as analysts praised the company’s ability to adapt to challenging conditions in the automotive sector.
The transport safety tech firm expects to reach cash flow break-even in 2025 after cutting $12 million in annual costs through a company-wide restructure.
Shares in Naked Wines PLC (AIM:WINE, OTCQX:NWINF) surged 16% in early trading after the company unveiled a new strategy focused on cash generation, leaner operations, and long-term growth.
The wine subscription business said it expects to unlock £75 million from its balance sheet, primarily by liquidating £40 million of excess inventory. It is now adjusted free cash flow positive and plans to start shareholder distributions soon.
Bradda Head Lithium Ltd (AIM:BHL, OTC:BHLIF, TSX-V:BHLI), which is developing projects in Arizona and Nevada, has welcomed a US Presidential Executive Order aimed at boosting domestic mineral production in America.
The Executive Order, issued on 20 March 2025, is titled Immediate Measures to Increase American Mineral Production.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) has updated investors on its ongoing programme for the feasibility study of the Bilboes project, which is seen as a transformational project.
The company, in a statement, said it now going to review several optimisation options that could improve project economics and reduce upfront capital costs.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) is expecting a sharp increase in royalty income in 2025, driven by rising production volumes across its copper and cobalt assets and supported by what it called positive commodity price "tailwinds".
The London and Toronto-listed royalty and streaming company, which focuses on critical minerals, said on Thursday that it anticipates meaningful growth in volumes this year, underpinned by operational momentum at key producing sites and contributions from its recently acquired copper stream over the Mimbula mine.
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) expects to reach cash flow break-even this year after implementing a $12 million reduction in annual operating expenses as part of a company-wide reorganisation aimed at sharpening focus and efficiency.
The London-listed AI-driven transport safety company said it had completed a strategic overhaul of its management structure and cut expenditure across engineering and corporate functions.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has reached a key milestone in the clinical development of its peanut allergy vaccine with healthy volunteers now receiving the highest planned doses and no safety issues reported.
The AIM-listed biotech said on Thursday that the final phase of its Phase I/IIa PROTECT trial is underway, with its vaccine candidate, known as VLP Peanut, being tested at doses beyond the expected therapeutic range. The aim is to establish a strong safety margin before moving into a larger Phase IIb study.
Silver Mines Ltd has kicked off a 2,000-metre diamond drilling program at the Bowdens Silver Project, with the goal of collecting both PQ (85.0 mm diameter) and HQ (63.5 mm diameter) core samples to cover the first 10 years of production.
This “Geo-Met” drilling program is designed to produce concentrate samples for potential offtake partners, as well as data to inform transportation certification and tailings processing optimisation.